Inhibition of Acetylcholinesterase ( AC hE): A Potential Therapeutic Target to Treat Alzheimer's Disease
Yong Li, X.-Q. Zhang, Lijuan Jiang, Yuan Li, Tingting Cao, Xia Li, Lin Dong, Ying Li, Shufan Yin
Abstract
Yong Li, X.-Q. Zhang, Lijuan Jiang, Yuan Li, Tingting Cao, Xia Li, Lin Dong, Ying Li, Shufan Yin
Abstract
A new series of icariin derivatives were synthesized and evaluated for their in vitro acetylcholinesterase (AChE) inhibitory activity. Most of the tested compounds exhibited high AChE inhibition and low toxicity, and among which compounds 1, 2, and 10 were the most potent (IC50 = 71.52 ± 22.43, 8.28 ± 1.45, 5.830 ± 1.78 nm, respectively).
OpenAlex reports 23 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A new series of icariin derivatives were synthesized and evaluated for their in vitro acetylcholinesterase (AChE) inhibitory activity. Most of the tested compounds exhibited high AChE inhibition and low toxicity, and among which compounds 1, 2, and 10 were the most potent (IC50 = 71.52 ± 22.43, 8.28 ± 1.45, 5.830 ± 1.78 nm, respectively).
Key concepts: Acetylcholinesterase, Disease, Alzheimer's disease, Pharmacology, Chemistry, Neuroscience, Biochemistry, Medicine